No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ETON241220P7500
- 0.05
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.15High0.05Low
0.15Open0.05Pre Close156 Volume2 Open Interest7.50Strike Price810.00Turnover0.00%IV40.73%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma251.40Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Craig-Hallum Initiates Eton Pharmaceutical(ETON.US) With Buy Rating
Eton Pharmaceuticals Closes Acquisition of Increlex (Mecasermin Injection)
Eton Pharmaceuticals Closes Acquisition Of Increlex(R) (Mecasermin Injection) >ETON
Express News | Eton Pharmaceuticals Closes Acquisition of Increlex® (Mecasermin Injection)
Eton Pharmaceuticals Announced The Full Readout From The Clinical Trial Evaluating PKU GOLIKE As A Protein Substitute For Phenylketonuria In Patients During Prolonged Fasting Periods
Express News | Eton Pharmaceuticals Announces Final Readout of Pku Golike® Clinical Trial